Top News

  • Lowden named chief information officer for IU School of Medicine

    Veteran information technology executive Rob Lowden will join IU School of Medicine on January 1 in the newly created role of executive associate dean and chief information officer. Lowden, who is currently associate vice president of enterprise software at Indiana University, will be responsible for developing and implementing a comprehensive information technology strategy for the school’s statewide nine-campus system.

    “To be a truly excellent medical school, we need to have access to the most advanced technologies and the ability to analyze complex data to drive decision making,” said IU School of Medicine Dean Jay L. Hess, MD, PhD, MHSA, executive vice president for university clinical affairs. “I am confident that, under Rob’s leadership, IU School of Medicine will implement innovative IT solutions that enhance our ability to educate physicians, conduct impactful research and deliver high-quality patient care.”

    Lowden will join the school’s executive leadership team and serve as one of six executive associate deans, each of whom has oversight of a critical aspect of the school’s mission and operations. He will lead the development and optimization of school-wide information systems, technologies, applications, and services, and will oversee IT alignment with partners such as Indiana University Health and the Regenstrief Institute.

    For more on Lowden’s recent appointment, read the full news release.

    Back to Top ▲

  • Faculty physicians earn Indianapolis Monthly “Top Doctors” honors

    More than 400 IU School of Medicine faculty members were recognized as “Top Doctors” by Indianapolis Monthly in the magazine’s November issue.

    “It is gratifying to see so many of our faculty recognized for their extraordinary expertise, but we know that the real measure of our success is our ability to improve patients’ lives,” said David Ingram, MD, executive associate dean for clinical affairs and president of IU Health Physicians. “All you have to do is walk through one of our hospitals to know IU School of Medicine is home to countless ‘Top Doctors’ who are compassionate and skilled, and who are transforming health care.”

    The magazine’s annual list of top doctors is compiled by Castle Connolly Medical Ltd., a health care research and information company. The company asks other physicians which doctors they would see themselves or send a family member to for care. In total, the magazine recognized 900 physicians working in more than 60 specialties in Marion and eight surrounding counties.

    IU School of Medicine faculty who were cited include those working at partner hospital systems such as Indiana University Health, Eskenazi Health and the Roudebush VA Medical Center, and also include approximately 150 volunteer faculty who volunteer their time teaching IU School of Medicine learners.

    Back to Top ▲

  • Have a great story to tell about IU School of Medicine? Start blogging!

    The IU School of Medicine Blogs Hub is a great platform for promoting the work and stories of the school’s faculty, staff and students. A self-publishing tool, bloggers are able to post their own content when they want--no timely review process required. Below are a few tips and tricks to creating captivating content on behalf of the largest medical school in the country:

    1. Audience: Who’s it for?
      First things first--who are you writing for? Prospective students? A potential donor? A reporter with the media? Defining your audience will set the tone for the remainder of your blog-writing journey. It’ll influence the way in which you write, the stories you tell and ultimately, your call to action for the reader. Please keep in mind that the Blogs Hub pages are designed for external audiences. If you’re looking to reach faculty from another campus, an e-Newsletter, MedNet document or Box folder may be a better route. 

    2. Angle: What’s unique about the story you’re telling?
      Perhaps a new faculty member plays in a rock band on the side or your department recently acquired a rare piece research technology that looks like a spaceship. Whatever it is, make sure it’s interesting and answers the question, “Why should the reader care?” 

    3. Make your headline a hero, not a zero
      The headline is the first thing a reader sees when scrolling through endless amounts of content on the web. By writing a great headline, you’re more likely to catch the reader’s attention, driving them to your blog post. Use words that evoke power and emotion, and avoid common words or plainly paraphrasing the first sentence of the content itself. CoSchedule--a marketing tool utilized by the Office of Strategic Communications--offers this great resource if you find yourself stuck in a headline rut. 

    4. The power of proofing
      Have a colleague give your blog a quick read to check for spelling and grammatical errors, as well as to make sure the content flows. A second, and sometimes third, set of eyes never hurt anyone (or any blog). You may also reach out to someone in the Office of Strategic Communications if you’re in a proofing pinch and would like a team member to review. 

    5. Get graphic
      Not literally, but utilizing good graphics and images within your post adds a new element for your reader. Throw out some cool stats using an infographic or take the reader inside a laboratory with some “live action” photos of research. Please be sure to use horizontal images whenever possible as they align with the blogging platform much better than vertical images.
    Still haven’t obtained blogger access? Submit your request here and start writing.

    Back to Top ▲

  • Submit news for year-end issues of INScope

    It’s almost December, and that means there are just a few editions of INScope remaining in 2018. Coinciding with holiday and semester schedules, INScope will take a two-week publication break in late December and early January. The last issue of 2018 will be distributed on Thursday, December 20. Publication will resume in the new year on Thursday, January 10.

    Have news to share with the IU School of Medicine community? Submit news items to scopemed@iu.edu. INScope editorial guidelines are available on MEDNet.

     

    Back to Top ▲

Research News

  • NIH-funded repository is Amazon.com of Alzheimer’s research

    At first blush, Tatiana Foroud, PhD, doesn’t seem to have much in common with Jeff Bezos. Foroud is the chair of the Department of Medical and Molecular Genetics at Indiana University School of Medicine. Bezos, as everyone knows, is the billionaire founder of Amazon.

    But it turns out, both are masters of logistics and adept at fulfilling customers’ orders and delivering them anywhere in the world.

    In Foroud’s case, the precious cargo she is charged with handling is blood, DNA and other samples donated by people with Alzheimer’s disease and other dementias. And the customers who await her deliveries are researchers who mine the samples for clues about what causes the disorders and how we might slow or prevent them.

    Foroud runs the National Centralized Repository for Alzheimer’s Disease and Related Dementias, a biobank funded by the National Institute on Aging, a division of the National Institutes of Health. The NIA recently awarded Foroud a new $12 million grant to substantially expand the repository to keep up with growing demand from researchers.

    “These specimens are incredibly important for research,” said Foroud, the Joe C. Christian Professor of Medical and Molecular Genetics. “A lot of what researchers are using them for is to develop tests so you can identify people with dementia before symptoms occur. With any new trial or new medication, it’s much harder to fix something that’s broken than to try to stop it from breaking. These samples allow us to test ideas and look for answers.”

    For more on the repository and Foroud’s role, read the Research Updates blog post.

    Back to Top ▲

  • Grant helps researchers unravel role of glucose, fats in bone cancer

    A $1.2 million Department of Defense grant has been awarded to an IU School of Medicine physician whose research explores a cascade of events that decreases quality of life and treatment responses for patients with metastatic bone cancer.

    Theresa Guise, MD, hopes to understand the role of the tumor-bone microenvironment on glucose metabolism and the role that a high-fat diet plays in the process. Her work is supported by the U.S. Army Medical Research Acquisition Activity through award W81XWH-18-1-0678.

    An endocrinologist, Guise is the Jerry and Peggy Throgmartin Professor of Oncology and professor of medicine at IU School of Medicine, and a co-leader of the Tumor Microenvironment and Metastasis research program at the Indiana University Melvin and Bren Simon Cancer Center.

    “One of the reasons we are studying high-fat diets in mice is to mimic our population in Indiana,” Guise said. “It is known that once cancer is in the bone, it causes bone destruction and the risk of fracture is increased. Diabetes also increases the risk for bone fractures. Our recent data show that bone destruction in the setting of a high-fat diet can induce diabetes. We believe this high glucose load can further impair bone quality, leading to a downward spiral.”

    Read the full news release to learn more about the questions Guise aims to answer and how the findings will be used to inform cancer therapy.

     

    Back to Top ▲

  • New research shows genetic impact on risk of alcoholism

    Indiana University School of Medicine researchers are learning more about the role genetics play in alcohol dependence, finding genetics and environment each play a role in a person’s risk of developing alcoholism.

    “No one is genetically ‘destined’ for alcoholism,” said Howard Edenberg, PhD, a distinguished professor in the IU School of Medicine Department of Biochemistry and Molecular Biology and one of the study’s main authors. “We found there is no single gene for alcoholism. Many variants in many genes contribute, and the environment plays an equally important role.”

    The study was carried out by a working group of the Psychiatric Genomics Consortium Use Disorder, a worldwide collaboration among many groups and individuals. It is the largest study to date that looks at risk genes of alcohol dependence. In this Faculty News Q&A blog post, Edenberg describes more about their findings and what they’re studying next.

     

    Back to Top ▲

Faculty and Staff News

  • Remembering Grzegorz Nalepa, MD, PhD

    Grzegorz Nalepa, MD, PhD, associate professor of pediatrics, associate professor of medical and molecular genetics, and adjunct associate professor of biochemistry and molecular biology, passed away earlier this week.

    D. Wade Clapp, MD, chairman, Department of Pediatrics, and physician-in-chief, Riley Hospital for Children at IU Health, shared the following message with colleagues:

    “Grzegorz has been a beloved physician-in-training and subsequently faculty member at Riley since he arrived as an intern in 2006, graduating among the first class of Morris Green Scholars. He is a rare individual who was both a superior clinician and an extraordinary physician-scientist. His compassion and devotion to his patients and their families was evident in the exceptional bond he shared with them. He exemplified the highest ideals of what it means to be a physician: to heal and to care. 

    He was a tremendously successful scientist who in his short career mentored many individuals at multiple levels of training. His laboratory was not only successful in publishing their work, but had a wall full of journals where his work was featured on the cover. His patients, students and colleagues broadly cherished his kind spirit, brilliance, wit and commitment. He will surely be missed.”

    Arrangements are pending.

    Back to Top ▲

  • Remembering T.-K. Li, MD

    Ting-Kai, Li, MD, an Indiana University Distinguished Professor Emeritus and former director of the National Institute on Alcohol Abuse and Alcoholism, passed away on Sunday, November 18, at age 84.

    Read this Faculty News blog post for insights from colleagues about Dr. Li’s impact on Indiana University, the study of alcoholism and the careers of those he helped mentor.

    Back to Top ▲

  • Faculty reminder: It’s time to prepare for annual review

    With the end of the year approaching, full-time faculty are reminded to begin preparing for their annual review. Reviews should occur in the first quarter of 2019 for work completed from January-December 2018. 

    New this year, Digital Measures Activity Insight (DMAI) will be used to complete the annual review and is now available for faculty and administrative leaders via One.iu.edu. DMAI provides department chairs and administrative leaders the ability to report on specific activity categories and allows faculty the opportunity to generate their annual report document and the IUPUI-formatted CV. DMAI has been expanded to capture IU School of Medicine-specific data such as IU Health Physicians clinical metrics and medical student course information. Faculty will be expected to confirm and update all 2018 activity in DMAI and download the IU School of Medicine Faculty Annual Review Report. Additional information and prior years’ activity may also be added, but is not required. 

    The Faculty Annual Review Guidelines include a summary of the objectives and responsibilities of faculty members and chairs/regional campus deans/directors. In addition, there is an IU School of Medicine DMAI “cheat sheet” that identifies the essential activity screens to review and update.  There is also a Faculty Support Guide available in the DMAI application to assist with navigation and functionality.

    All full-time faculty members should work directly with their department chair and administrative leaders to complete their required annual review by April 30, 2019.

    Questions? Contact Mary Dankoski, PhD, at mdankosk@iu.edu or Melody Darnall at mldarnal@iu.edu.

    Back to Top ▲

  • Chmiel named chief of Pediatric Pulmonary, Allergy and Sleep Medicine

    James Chmiel, MD, MPH, will join IU School of Medicine in January as the division chief of Pediatric Pulmonology, Allergy and Sleep Medicine. Chmiel is currently professor of pediatrics in the division of pediatric pulmonology and allergy/immunology at Case Western Reserve University School of Medicine and Rainbow Babies and Children’s Hospital. A faculty member at Case Western since 1998, he also is the director of the pediatric program of the Cystic Fibrosis Care Center and the director of the Cystic Fibrosis Foundation Therapeutics Development Center.

    A graduate of the University of Notre Dame, Chmiel earned his medical degree and master of public health degree from the University of Michigan. He completed his pediatrics residency at Children’s Memorial Hospital/Northwestern University Medical School and a pediatric pulmonology fellowship at Rainbow Babies and Children’s Hospital/Case Western Reserve University School of Medicine.  

    Chmiel’s research involves understanding the inflammatory response of the lung, particularly as it relates to cystic fibrosis and asthma, and the impact of anti-inflammatory therapeutics upon that response. He is chair of the Cystic Fibrosis Foundation’s Anti-Inflammatory Working Group, and a member of the foundation’s Clinical Research Committee. In 2014, Chmiel began serving on the pediatric pulmonology sub-board of the American Board of Pediatrics and became its chair in January 2017.

    Back to Top ▲

  • Dahlem appointed new division chief of Clinical Pharmacology

    Andrew Dahlem, PhD, joined IU School of Medicine on November 15 as senior research professor of medicine and division chief of Clinical Pharmacology.

    A graduate of Ohio State University, Dahlem earned his PhD in toxicology at the College of Veterinary Medicine at the University of Illinois-Urbana. In addition, he has completed several leadership courses at MIT and Harvard Business School. Most recently, Dahlem served as vice president and chief operating officer of Lilly Research Laboratories and Lilly Research Laboratories in Europe. Hired by Eli Lilly and Company in 1990, he served in a variety of senior management positions during his tenure, including roles in research operations, compliance, business development and competitive intelligence. 

    “Andy will play a central role in the advancement of the Division of Clinical Pharmacology,” wrote IU School of Medicine Department of Medicine Chair Mark Geraci, MD, in a message announcing Dahlem’s appointment. “His expertise in toxicology, pharmacokinetics and pharmacodynamics will augment the expertise resident within the division. Moreover, his extensive expertise in the pharmaceutical industry will position the division and its allied members to have leading roles within the Precision Health Initiative, as well as a central role in the development of the new pharmaceutical sciences program here at IU School of Medicine.”

    Back to Top ▲

  • Facilitators, small group leaders needed for Transitions 2

    Transitions 2 is two-week course designed to prepare students for clerkships and for learning in a clinical environment. In April, 290 students on the Indianapolis campus will be enrolled in the Transitions 2 course, requiring a large number of facilitators, small group leaders, procedure trainers and clinical faculty to help with physical examination review. The course will be held from Tuesday, April 9, to Friday, April 19. If you are available to help on any of these days, contact Scott Renshaw, MD, Transitions 2 Indianapolis site director, at serensha@iupui.edu.

    Back to Top ▲

Opportunities

  • Apply by January 16 for research enhancement grants

    The IU School of Medicine Research Enhancement Program is designed to stimulate research productivity at the statewide regional campuses, including the Bloomington Medical Sciences Program. All full-time center/medical sciences faculty, regardless of tenure status, having an appointment of assistant/associate/full professor or assistant/associate/full scientist at time of submission, are eligible to apply for a Research Enhancement Grant. Primary appointment must be in IU School of Medicine.  

    More information and application submission details are available. Application deadline is Wednesday, January 16.

    Back to Top ▲

  • Biomedical research grant applications due January 16

    The Biomedical Research Grant program is open to all full-time IU School of Medicine faculty, regardless of tenure status, who have an appointment as assistant/associate/full professor or assistant/associate/full scientist. Research projects that will benefit from this grant program include projects of investigators new to IU School of Medicine who do not yet have extramural funding and who need support to acquire the preliminary data necessary to compete for extramural funding; and research projects of established IU School of Medicine investigators who are between funding periods from extramural sources.

    Application deadline is Wednesday, January 16. More details are available.

    Back to Top ▲

  • Showalter Trust funds available for biomedical research

    Since 1975, IU School of Medicine has received research funding through gifts made possible from the Ralph W. and Grace M. Showalter Research Trust Fund. Eligible biomedical research, as described by the benefactors includes “the type of medical research that is most likely to permanently benefit mankind.” Donor intent prohibits the use of Showalter Trust funds for research in psychiatry, sociology or social studies.

    Current full-time faculty (non-visiting status) having a primary appointment in IU School of Medicine and a rank of assistant professor or assistant scientist are eligible to apply for Showalter Trust funding.

    Preliminary application deadline is Wednesday, January 9. More details are available.

    Back to Top ▲

  • Neuro-immunology is topic of December 5 Campbell Lecture

    Linda Lau, MD, PhD, MBA, of the David Geffen School of Medicine at UCLA, will present the Campbell Lecture at 5 pm, Wednesday, December 5, in Goodman Hall Auditorium in the IU Health Neuroscience Center. “New Directions in Neuro-immunology and Brain Tumor Immunotherapy” is the tile of Lau’s presentation.

    Back to Top ▲

  • December 5 lecture to focus on “Civil War surgeons and narrative space”

    Jane E. Schultz, PhD, professor of English and director of literature at IUPUI, will present “Surgical Silences: Civil War Surgeons and Narrative Space” from noon-1 pm, Wednesday, December 5, in the Ruth Lilly Medical Library. Schultz will discuss the representation of surgeon-soldier interactions from surgical letters, diaries and memoirs and what happens when language fails to summarize and describe, despite surgeons’ fluency in the clinical register. 

    The lecture is being held in conjunction with the National Library of Medicine’s Life and Limb traveling exhibit hosted by the Ruth Lilly Medical Library. Continuing Medical Education credit is available. The lecture will be recorded and placed on Kaltura. With questions, contact Sue London at slondon@iu.edu or 317-274-2281.

    Back to Top ▲